Award notice Supplies
2023/0491 - Ixecizumab [80 mg/1 ml sol inj caneta]
Notice published in Portuguese. The AI analysis summarises it for you in your language.
- Public buyer
- Unidade Local de Saúde Santa Maria, E.P.E.
Lisboa - Place of performance
- Lisboa
- Estimated value
- €251,018 excl. VAT
- Amount awarded
- €251,018 excl. VAT
- Planned end of contract
- 19 January 2027
likely re-tender around October 2026 - Bids received
- 1
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Restricted procedure
You first submit an application; only shortlisted candidates are invited to bid. - Publication
- 21 July 2026
- Notice language
- Portuguese
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
IXECIZUMAB [80 MG/1 ML SOL INJ CANETA
Awarded to
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €247,856
- Median
- €358,774
- A quarter above
- €902,500
Amounts awarded (excl. VAT) over the last 3 years for 49 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| 2026/0006 - Carfilzomib [60 mg pó sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
AMGEN BIOFARMACEUTICA, LDA | €655,674 |
| 2026/0006 - Olaparib [150 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
ASTRAZENECA- PROD.FARM LDA | €266,176 |
| 2026/0098 - Agalsidase beta [35 mg f/amp] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
SANOFI-PRODUTOS FARMACÊUTICOS,LDA | €252,123 |
| 2024/0782 - Dexametasona [700 µg impl intravítreo emb] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
ABBVIE, LDA | €258,751 |
| 2026/0006 - Lorlatinib [100 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. · 20 October 2026 |
LAB. PFIZER, LDA | €55,301 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 502317-2026.